-
EP3489250
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3489250
| EP3489250 - CRYSTAL FORM OF DAPAGLIFLOZIN INTERMEDIATE AND PREPARATION METHOD THEREFOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.03.2023 Database last updated on 19.07.2024 | |
| Former | Grant of patent is intended Status updated on 18.07.2022 | ||
| Former | Request for examination was made Status updated on 26.04.2019 | ||
| Former | The international publication has been made Status updated on 26.01.2018 | Most recent event Tooltip | 31.03.2023 | Application deemed to be withdrawn | published on 03.05.2023 [2023/18] | Applicant(s) | For all designated states Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Economic and Technological Development Zone Lianyungang, Jiangsu 222047 / CN | [N/P] |
| Former [2019/22] | For all designated states Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | Inventor(s) | 01 /
LI, Xiang Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | 02 /
YU, Jun Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | 03 /
YU, Haizhou Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | 04 /
WANG, Jinjia Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | 05 /
HE, Lei Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | 06 /
DU, Zuyin Economic and Technological Development Zone Lianyungang Jiangsu 222047 / CN | [2019/22] | Representative(s) | Viganò, Elena, et al Dragotti & Associati S.r.l. Via Nino Bixio, 7 20129 Milano / IT | [2019/22] | Application number, filing date | 17830500.9 | 21.07.2017 | [2019/22] | WO2017CN93833 | Priority number, date | CN201610587582 | 22.07.2016 Original published format: CN201610587582 | [2019/22] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018014866 | Date: | 25.01.2018 | Language: | ZH | [2018/04] | Type: | A1 Application with search report | No.: | EP3489250 | Date: | 29.05.2019 | Language: | EN | [2019/22] | Search report(s) | International search report - published on: | CN | 25.01.2018 | (Supplementary) European search report - dispatched on: | EP | 28.01.2020 | Classification | IPC: | C07H15/04, C07H1/00, C07D309/10, A61P3/10 | [2019/22] | CPC: |
A61P3/10 (EP,KR,US);
C07H15/04 (EP,KR,US);
C07H7/04 (US);
C07D309/10 (US);
C07H1/00 (EP,KR,US);
C07B2200/13 (KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/22] | Title | German: | KRISTALLINE FORM EINES DAPAGLIFLOZIN-ZWISCHENPRODUKTES UND HERSTELLUNGSVERFAHREN DAFÜR | [2019/22] | English: | CRYSTAL FORM OF DAPAGLIFLOZIN INTERMEDIATE AND PREPARATION METHOD THEREFOR | [2019/22] | French: | NOUVELLE FORME CRISTALLINE D'INTERMÉDIAIRE DE DAPAGLIFLOZINE ET SON PROCÉDÉ DE PRÉPARATION | [2019/22] | Entry into regional phase | 07.01.2019 | Translation filed | 07.01.2019 | National basic fee paid | 07.01.2019 | Search fee paid | 07.01.2019 | Designation fee(s) paid | 07.01.2019 | Examination fee paid | Examination procedure | 07.01.2019 | Examination requested [2019/22] | 27.07.2020 | Amendment by applicant (claims and/or description) | 19.07.2022 | Communication of intention to grant the patent | 30.11.2022 | Application deemed to be withdrawn, date of legal effect [2023/18] | 20.12.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2023/18] | Fees paid | Renewal fee | 15.07.2019 | Renewal fee patent year 03 | 14.07.2020 | Renewal fee patent year 04 | 15.07.2021 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.07.2022 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]US2013267694 (XU BAIHUA [US], et al) [I] 1* the whole document * | International search | [X]WO2013152654 (THERACOS INC [US]) [X] 1-13 * , description, and embodiments 22-24 *; | [X]CN104109179 (HANGZHOU HUADONG MEDICINE GROUP BIOLOGY ENG RES CO LTD) [X] 1-13* , description, paragraphs [0052]-[0060] *; | [X]WO2015132803 (MSN LAB PRIVATE LTD [IN], et al) [X] 1-13 * , description, page 8, paragraph 1, and embodiment 4 *; | [X]CN105481915 (BEIJING WINSUNNY PHARMACEUTICAL CO LTD) [X] 1-13 * , claim 1, and description, embodiments 1-2 * |